Biotechnology from bench to business

• Follow GEN on:
• Log In / Register | Subscribe

Current Issue

Top Keywords

• ADME/Tox
• Angiogenesis
• Apoptosis
• Antibodies
• Biomanufacturing
• Biomarkers
• Bioreactors
• Biosimilars
• Biotherapeutics
• Cancer
• Cancer Stem Cells
• Cell Culture
• Cell-Based Assays
• Chromatography
• Contract Manufacturing
• Gene Expression
• Genetics
• Genomics
• Glycan Analysis
• HPLC
• Immunoassay
• Liquid Handling
• mAb Production
• mAb Therapeutics
• Microarrays
• Multiplexing
• Next-Generation Sequencing
• Peptide Therapeutics
• PCR
• Pharmacokinetics
• Protein Characterization
• Protein Expression
• Protein Production
• Protein Therapeutics
• qPCR
• Reagents
• RNA-Seq
• Sequencing
• Single-Use Systems
• Small Molecules
• Stem Cells
• Transfection
• Vaccines

Roche - Related Content

• GEN Articles
• Insight & Intelligence™
• GEN News Highlights
• GEN Podcasts
• Video Channel
• New Products
• GEN Polls

GEN articles

• Assay Tutorials: Measurement of Cardiomyocyte Contractions
  Detection of Compound Effects on Beating Frequency Made Possible with New Instrument
• Tutorials: Accelerated Workflow for RT-qPCR Analysis
  Kit from Roche Developed to Facilitate Fast, Reproducible Gene-Expression Data
• Tutorials: Sequencing-Based HLA Typing Using RNA
  Advances in Extractin and Enzymology Open Door for RNA as Alternative to Genomic DNA
• Tutorials: In Search of a Reliable Scale-Down Model
  Roche Scientists Evaluate the Capabilities of a Dasgip Parallel Bioreactor System
• Assay Tutorials: Investigating Cell Invasion and Migration
  Beyond Endpoint Analysis: Real-Time Monitoring Enables Greater Insight into Cellular Behavior

• MORE ROCHE RELATED GEN ARTICLES

Insight & intelligence™

• Will Roche Really Drop Illumina and Seek out Another Sequencing Firm?
  March 12, 2012
  Oxford Nanopore and PacBio both have exciting technologies, but Illumina remains market leader.
• Roche, Illumina Duke It Out in Potential $5.7B Takeover Deal
  March 1, 2012
  Roche’s hostile $44.50 per share bid could also spark additional sequencing acquisition wars.
• Enzo Sues Roche, Gen-Probe, and Life Technologies in Patent Infringement Case
  February 29, 2012
  Patent under dispute expires in 2023, and defendants plan on fighting the lawsuit.
• Sequencing Firms Set Up Centers to Advance Genomics Research and Instrument Sales
  February 20, 2012
  Strategy provides a feedback loop to improve instrumentation and develop new applications.
• Avastin Label Changes Reignites Debate: Is OS or PFS the Better Regulatory Endpoint?
  December 13, 2011
  A recent panel discussion set the stage for defining standards for drug approval as separate from those for treatment decisions.

• MORE ROCHE RELATED INSIGHT & INTELLIGENCE™

GEN news highlights

• Six Suitors Join Bristol-Myers in Considering a Bid for Amylin
  
• Roche Terminates Pivotal Heart Disease Study with Dalcetrapib
  
• Roche Reports Sales Dip in First Quarter of This Year
  
• Seattle, Millennium Tap Ventana to Develop Companion Dx for Lymphoma Drug
  
• Illumina Shuns Roche’s Improved Acquisition Offer of $6.5B
  

• MORE ROCHE RELATED GEN NEWS HIGHLIGHTS

GEN podcasts

• Stapled Peptides Making Progress
  Gregory L. Verdine, Ph.D., Harvard College Professor and Erving Professor of Chemistry, Department of Cellular and Molecular Biology, Harvard University, and Founder and Co-Chairman, Scientific Advisory Board, Aileron Therapeutics

• MORE ROCHE RELATED GEN PODCASTS

Video channel

• Roche Applied Science: LightCycler 480
  

• MORE ROCHE RELATED VIDEO CHANNEL

New products

	Roche Applied Science Real-Time PCR Cycler The new LightCycler® Nano Instrument is a 32-well format real-time PCR cycler. Silent and compact, this benchtop instrument is useful for laboratory end users performing real-time PCR on a daily basis. The system uses standard PCR strips and can
	PerkinElmer Imaging Agent The HER2Sense™ fluorescent, discovery-research imaging agent is an antibody-based optical probe for research applications. It is based on trastuzumab, a therapeutic antibody supplied by Roche Custom Biotech used to detect the HER2/Neu receptor

• MORE ROCHE RELATED NEW PRODUCTS

GEN polls

• Roche’s Ploy for Illumina
  

• MORE ROCHE RELATED GEN POLLS

Home | Terms of Use | Privacy Statement | Legal